Canadian Melanoma Conference - Home


HOME \| PROGRAM \| SPEAKERS \| REGISTRATION & ACCOMMODATION \| SPONSORS \| BANFF
2013 Canadian Melanoma Conference Mark Your Calendars! February 21 to 24, 2013 Rimrock Resort Hotel, Banff, Alberta The Canadian Melanoma Conference is Canada's flagship meeting on the research and treatment of melanoma. It brings together Medical Oncologists, Surgeons, Dermatologists, Radiotherapists, Pathologists, Molecular Biologists, and Immunologists to review the latest evidence and explore new therapies. The majority of the information on this site still pertains to the 2012 event. The dates for the 2013 event appear above and more information will be posted as it becomes available. 2012 Presentation Handouts Handouts from speakers who have granted permission are listed in the order in which they appeared in the final program. Some files are quite large and may take several minutes to download. Sébastien Labonté - Pathologic Evaluation of Melanomas Suzanne Kamel-Reid - Personalized Medicine at Work: Genetic Analysis of Melanomas Reinhard Dummer - Proliferation or Invasion: What Drives Melanoma Progression? Charles Balch - How Staging Affects Adjuvant Therapy Decision for Stage III Melanoma Caroline Robert - Various Profiles of Responses to RAF Inhibitors Cheryl Rosen - Sunscreens: An Update Sanjiv Agarwala - Where Does Interferon Stand in 2012? Ezekiel Weis - Uveal Melanoma Vernon Sondak - Update on Sentinel Node Biopsy and the Surgical Management of Positive Nodes Jedd Wolchok - Immunotherapy for Melanoma: The End of the Beginning David Hogg - The Occasional Melanoma Oncologist Jeff Weber - Overcoming Checkpoint Inhibition with PD-1 Antibody Ryan Sullivan - Improving the Effectiveness of BRAF Inhibitors 2012 Learning Objectives Communicate state-of-the-art knowledge in biology, pathogenesis, and melanoma pathology Review the biological basis of bRAF inhibition and the clinical implications in the management of melanoma Present pre-clinical and clinical research regarding MEK inhibition in melanoma Provide an update on the use of anti-CTLA4 therapy, including the evaluation of response and the management of immune-related toxicities Share novel research strategies and initiatives being conducted across Canada Identify new targets and targeted agents in the treatment of melanoma Review the multi-centre clinical trials currently open in Canada Identify key industry partners who would prioritize the development of products and programs in melanoma management in Canada Continue to build the network of basic and clinical investigators in order to promote translational and clinical research across Canada Discuss short- and long-term research strategies
HOME \| PROGRAM \| SPEAKERS \| REGISTRATION & ACCOMMODATION \| SPONSORS \| BANFF
Canadian Melanoma Conference c/o BUKSA Strategic Conference Services Suite 307, 10328 - 81 Avenue NW, Edmonton, AB T6E 1X2 Phone: 780.436.0983 ext. 234 Fax: 780.437.5984 Email:melanoma@buksa.com